Picture of Accolade logo

ACCD Accolade News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

U.S. RESEARCH ROUNDUP-Equity Residential, Goldman Sachs, Marsh & Mclennan

June 28 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Equity Residential, Goldman Sachs and Marsh
& Mclennan, on Friday. 
    
    HIGHLIGHTS
     * Equity Residential  EQR.N : Piper Sandler raises to overweight from neutral
     * Goldman Sachs  GS.N : RBC raises target price to $435 from $405    
     * Marsh & Mclennan  MMC.N : RBC raises target price to $228 from $210    
     * Pagerduty Inc  PD.N : Scotiabank initiates coverage with sector perform rating
     * Williams Companies Inc  WMB.N : JP Morgan raises target price to $47 from $42        
        
Following is a summary of research actions on U.S. companies reported by Reuters on Friday.
Stock entries are in alphabetical order.
    
     * Accolade Inc  ACCD.O : Canaccord Genuity cuts target price to $13 from $16
     * Accolade Inc  ACCD.O : D.A. Davidson cuts target price to $5 from $10
     * Accolade Inc  ACCD.O : Leerink Partners cuts target price to $9.50 from $15
     * Apogee Enterprises Inc  APOG.O : D.A. Davidson raises target price to $65 from $60
     * Baker Hughes Co  BKR.O : Jefferies raises target price to $46 from $45
     * BP  BP.N : Jefferies raises target price to $43.8 from $43.1
     * Calcimedica Inc  CALC.O : Jonestrading cuts target price to $15 from $22
     * Delta Air Lines Inc  DAL.N : Jefferies cuts target price to $56 from $58
     * Equity Residential  EQR.N : Piper Sandler raises to overweight from neutral
     * Equity Residential  EQR.N : Piper Sandler raises target price to $80 from $70
     * GE Aerospace  GE.N : Jefferies raises target price to $190 from $185
     * General Mills  GIS.N : Evercore ISI cuts target price to $72 from $76
     * General Mills  GIS.N : Piper Sandler cuts target price to $74 from $76
     * Goldman Sachs  GS.N : RBC raises target price to $435 from $405
     * Halliburton Co  HAL.N : ATB Capital Markets cuts target price to $51 from $53
     * Helmerich and Payne Inc  HP.N : ATB Capital Markets cuts target price to $45 from $49
     * Liberty Energy Inc  LBRT.N : ATB Capital Markets cuts target price to $24 from $26
     * Marsh & Mclennan  MMC.N : RBC raises target price to $228 from $210
     * McCormick & Company Inc  MKC.N : Jefferies raises target price to $74 from $73
     * Nike Inc  NKE.N : Jefferies cuts target price to $90 from $100
     * Nike Inc  NKE.N : HSBC cuts target price to $90 from $100
     * Nine Energy Service Inc  NINE.N : ATB Capital Markets cuts target price to $1 from $2.50
     * Pagerduty Inc  PD.N : Scotiabank initiates coverage with sector perform rating
     * Pagerduty Inc  PD.N : Scotiabank initiates coverage with target price $23
     * Patterson-UTI Energy Inc  PTEN.O : ATB Capital Markets cuts target price to $13 from $15
     * Propetro Holding Corp  PUMP.N : ATB Capital Markets cuts target price to $11.50 from $12
     * Recursion Pharmaceuticals Inc  RXRX.O : Leerink Partners cuts target price to $9 from $10
     * SM Energy Co  SM.N : Gerdes Energy Research raises target price by $1 to $60
     * SM Energy Co  SM.N : Roth MKM cuts target price to $52 from $58
     * SM Energy Co  SM.N : Stephens raises target price to $64 from $63
     * SM Energy Co  SM.N : Susquehanna cuts target price to $48 from $51
     * Viking Therapeutics Inc  VKTX.O : Morgan Stanley initiates coverage with overweight rating
     * Viking Therapeutics Inc  VKTX.O : Morgan Stanley initiates coverage with target price $105
     * Walgreens  WBA.O : Evercore ISI cuts target price to $10 from $17
     * Walgreens  WBA.O : Leerink Partners cuts target price to $11 from $17
     * Walgreens  WBA.O : Mizuho cuts target price to $15 from $19
     * Williams Companies Inc  WMB.N : JP Morgan raises target price to $47 from $42
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Accolade

See all news